# METHODIST HOSPITAL RESEARCH INSTITUTE: The role of GRK3-HDAC2 epigenetic pathway in neuroendocrine prostate cancer and immune evasion

**Lab Budget Score:** 55/100

| Field | Value |
|---|---|
| Organization | METHODIST HOSPITAL RESEARCH INSTITUTE |
| Location | HOUSTON, TX |
| Project | The role of GRK3-HDAC2 epigenetic pathway in neuroendocrine prostate cancer and immune evasion |
| Project number | 1R01CA315906-01 |
| Mechanism | R01 |
| Institute | National Cancer Institute |
| Award | $514,864 |
| Awarded | 2026-09-09 |
| Project period | 2026-09-09 to 2031-08-31 |
| UEI | XJUCJAYJWYV1 |

## Why this score
- Award of $400K or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11426413). Last refreshed: 2026-11-04T21:37:56.465Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.